(S)-2-((tert-Butoxycarbonyl)(methyl)amino)-3-cyclopropylpropanoic acid, 95%, 250mg

2-(4,4-Difluoropiperidin-1-yl)-N-(1-isopropylpiperidin-4-yl)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-amine, 98%, 10mg

Ethyl 4-(chloromethyl)benzoate, 95.0%, 5g

4,4'-(Cyclopent-1-ene-1,2-diyl)bis(5-methylthiophene-2-carbaldehydE), 97%, 100mg

7-Chloro-3,4-dihydroquinolin-2(1H)-one, 95.0%, 1g

Sodium Triacetoxyborohydride>80.0%(T)25g

8-Bromo-6-methylquinoline, 95.0%, 100g

Bredereck reagent, 90.0%, 100g

Gránulos de oro, mínimo 99,95 %, 1-6 mm, 5 g, envase de vidrio

(R)-1-(3-Bromo-2-methylphenyl)ethanamine hydrochloride, 100mg

3-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 95%, 100mg

tert-Butyl 7-(trifluoromethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, 95.0%, 1g

(S)-(-)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid>98.0%(T)25g